245 related articles for article (PubMed ID: 15225175)
1. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.
Labus JS; Bolus R; Chang L; Wiklund I; Naesdal J; Mayer EA; Naliboff BD
Aliment Pharmacol Ther; 2004 Jul; 20(1):89-97. PubMed ID: 15225175
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
3. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
4. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.
Labus JS; Mayer EA; Chang L; Bolus R; Naliboff BD
Psychosom Med; 2007 Jan; 69(1):89-98. PubMed ID: 17244851
[TBL] [Abstract][Full Text] [Related]
5. Internet-based assessment of bowel symptoms and quality of life.
Enck P; Kowalski A; Martens U; Klosterhalfen S
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1263-9. PubMed ID: 17099374
[TBL] [Abstract][Full Text] [Related]
6. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.
Spiegel BM; Gralnek IM; Bolus R; Chang L; Dulai GS; Mayer EA; Naliboff B
Arch Intern Med; 2004 Sep; 164(16):1773-80. PubMed ID: 15364671
[TBL] [Abstract][Full Text] [Related]
7. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
[TBL] [Abstract][Full Text] [Related]
8. A valid and reliable measure of constipation-related quality of life.
Wang JY; Hart SL; Lee J; Berian JR; McCrea GL; Varma MG
Dis Colon Rectum; 2009 Aug; 52(8):1434-42. PubMed ID: 19617757
[TBL] [Abstract][Full Text] [Related]
9. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.
Simmons Z; Felgoise SH; Bremer BA; Walsh SM; Hufford DJ; Bromberg MB; David W; Forshew DA; Heiman-Patterson TD; Lai EC; McCluskey L
Neurology; 2006 Nov; 67(9):1659-64. PubMed ID: 17101900
[TBL] [Abstract][Full Text] [Related]
10. The constipation severity instrument: a validated measure.
Varma MG; Wang JY; Berian JR; Patterson TR; McCrea GL; Hart SL
Dis Colon Rectum; 2008 Feb; 51(2):162-72. PubMed ID: 18172725
[TBL] [Abstract][Full Text] [Related]
11. The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease.
Spiller RC; Humes DJ; Campbell E; Hastings M; Neal KR; Dukes GE; Whorwell PJ
Aliment Pharmacol Ther; 2010 Sep; 32(6):811-20. PubMed ID: 20629976
[TBL] [Abstract][Full Text] [Related]
12. Content development of the Optometric Patient Anxiety Scale.
Court H; Greenland K; Margrain TH
Optom Vis Sci; 2007 Aug; 84(8):729-37. PubMed ID: 17700326
[TBL] [Abstract][Full Text] [Related]
13. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
[TBL] [Abstract][Full Text] [Related]
14. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
Carleton RN; Collimore KC; Asmundson GJ
J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms.
Kalaitzakis E; Carlsson E; Josefsson A; Bosaeus I
Scand J Gastroenterol; 2008; 43(9):1057-65. PubMed ID: 18609190
[TBL] [Abstract][Full Text] [Related]
16. The Injury Distress Index: development and validation.
Victorson DE; Enders CK; Burnett KF; Ouellette EA
Arch Phys Med Rehabil; 2008 Oct; 89(10):1893-902. PubMed ID: 18929018
[TBL] [Abstract][Full Text] [Related]
17. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
Smith GD
J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Generalized Anxiety Disorder Inventory (GADI).
Argyropoulos SV; Ploubidis GB; Wright TS; Palm ME; Hood SD; Nash JR; Taylor AC; Forshall SW; Anderson IM; Nutt DJ; Potokar JP
J Psychopharmacol; 2007 Mar; 21(2):145-52. PubMed ID: 17329293
[TBL] [Abstract][Full Text] [Related]
19. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.
Whitehead WE; Palsson OS; Feld AD; Levy RL; VON Korff M; Turner MJ; Drossman DA
Aliment Pharmacol Ther; 2006 Jul; 24(1):137-46. PubMed ID: 16803612
[TBL] [Abstract][Full Text] [Related]
20. Development of the Anxiety Change Expectancy Scale (ACES) and validation in college, community, and clinical samples.
Dozois DJ; Westra HA
Behav Res Ther; 2005 Dec; 43(12):1655-72. PubMed ID: 15922290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
